Live tape
Top 8, mentions 7d6,802SPCX1,298 mentions▲ +0.09GOOGL1,254 mentions▲ +0.05NVDA1,091 mentions▲ +0.09MSFT745 mentions▲ +0.04QQQ680 mentions▲ +0.08META605 mentions▲ +0.05SPY587 mentions▲ +0.06AMZN542 mentions▲ +0.06

Equity · Healthcare

HURA

NASDAQ

TuHURA Biosciences, Inc.

$2.25 +2.27% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for HURA to draw a line in its place.

Track this symbol on TradingView TradingView chart · our licensed closes: 5 sessions, 13 Jul – 17 Jul 2026
Market cap $143.4M
52-week range $0.4396 – $3.24
Avg volume 122.2K

as of Jul 17, 2026

HURA insider trades

SEC Form 4

HURA has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 28 May 2026.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
28 May 2026 Bianco James A. Chief Executive Officer Gift 150,000

HURA reported financials

SEC EDGAR XBRL SEC EDGAR

HURA reported revenue of $0 for the fiscal year ended 31 Dec 2025. Net income over the same period was −$30.1M.

Figure Reported Period
Revenue $0 31 Dec 2025 fiscal year
Net income −$30.1M 31 Dec 2025 fiscal year
Diluted EPS −$0.63 31 Dec 2025 fiscal year
Total assets $31.7M 30 Jun 2026 at period end
Total equity $18.5M 30 Jun 2026 at period end

HURA earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.14 —
31 Mar 2026 Q1 2026 −$0.13 —
31 Dec 2025 FY 2025 −$0.63 —
30 Sep 2025 Q3 2025 −$0.14 —
30 Jun 2025 Q2 2025 −$0.21 —
31 Mar 2025 Q1 2025 −$0.15 —
31 Dec 2024 FY 2024 −$1.21 —
30 Sep 2024 Q3 2025 −$0.54 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

HURA institutional holders

SEC Form 13F SEC EDGAR

4 of the 45 institutional funds we track reported a HURA position for the quarter ended 30 Jun 2026 — a combined $2.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management New position 454,535 $1.1M
AQR Capital Management Trimmed −30.1% shares 424,600 $994K
Citadel Advisors New position 232,319 $544K
Tudor Investment Corp New position 45,115 $106K

HURA fails-to-deliver

SEC CNS data SEC

On 14 Sep 2026, 9,576 shares of HURA failed to deliver (about $20K) — the latest of at least 13 consecutive trading days with recorded fails. The run reaches the start of the window we read, so it may have begun earlier.

Settlement date Shares failed Notional % of shares out
14 Sep 2026 9,576 $20K 0.015%
11 Sep 2026 19,221 $39K 0.030%
10 Sep 2026 9,163 $18K 0.014%
09 Sep 2026 1,434 $3K 0.002%
08 Sep 2026 2,947 $6K 0.005%
04 Sep 2026 7,456 $16K 0.012%
03 Sep 2026 334 $698 0.001%
02 Sep 2026 6,696 $14K 0.011%
01 Sep 2026 1,367 $3K 0.002%
31 Aug 2026 1,620 $3K 0.003%
28 Aug 2026 1,513 $3K 0.002%
27 Aug 2026 16,151 $34K 0.025%
26 Aug 2026 26,659 $54K 0.042%

Congressional trades in HURA

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in HURA is a purchase by Laurel M. Lee (house, FL), dated 25 Nov 2024.

Date Member Type Amount
25 Nov 2024 filed 07 Jan 2025 Laurel M. Lee house · Republican–FL Purchase $1K–$15K
18 Oct 2024 filed 21 Nov 2024 Laurel M. Lee house · Republican–FL Exchange $100K–$250K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings